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INTRODUCTION
Malaria is the major causes of morbidity and mortality in the 
world. The disease affects the populations of tropical and sub-
tropical areas worldwide. Of the 5 species of Plasmodium that 
cause malaria in humans, Plasmodium falciparum is the most 
dangerous and responsible for most morbidity and mortality 
[1]. Malaria control relies principally on prompt and accurate 
diagnosis and chemotherapy with effective antimalarial drugs 
[2]. Prompt and accurate diagnosis is the key to prevent mor-
bidity and mortality while it is avoiding unnecessary use of 
antimalarial agents. The traditional malaria diagnosis is based 
on the examination of stained blood smears under light mi-
croscope. The method remains the gold standard for malaria 
diagnosis as it is inexpensive and sensitive (5-10 parasites/µl 
blood) [3]. However, it is labor-intensive, time-consuming, and 
more importantly, requires skill and experienced microscopists. 
Recently, alternative methods, such as immunochromato-
graphic assay, molecular amplification method, fluorescence 
microscopy, mass spectrometry, and flow cytometry have been 
developed for malaria diagnosis [3-10]. These methods have 
some advantages and also some limitations. PCR is considered 
the most sensitive and specific method, but is expensive, re-
quiring PCR machine, relatively sophisticated and time-con-
suming procedure, which may not be applicable for malaria 
diagnosis in remote areas. Malaria rapid detection tests (RDTs) 
which are based on capture of the parasite antigen by mono-
clonal antibodies incorporated into a test strip provide a possi-
bility to replace microscopic diagnosis. Although there have 
been a number of RDTs commercially available, their sensitivi-
ty and specificity remain uncertain. RDTs can be divided into 
2 major types. The first type detects histidine-rich protein 2 
(HRP2), a protein uniquely synthesized by P. falciparum and 
present in the blood stream of an infected individual [11]. Some 
HRP2 tests are designed to also detect aldolase enzyme, a pro-
tein synthesized by all 4 human-infecting Plasmodium species 
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Abstract: Prompt and accurate diagnosis of malaria is the key to prevent disease morbidity and mortality. This study was 
carried out to evaluate diagnostic performance of 3 commercial rapid detection tests (RDTs), i.e., Malaria Antigen Pf/Pan
TM, 
Malaria Ag-Pf
TM, and Malaria Ag-Pv
TM tests, in comparison with the microscopic and PCR methods. A total of 460 blood 
samples microscopically positive for Plasmodium falciparum (211 samples), P. vivax (218), mixed with P. falciparum and P. 
vivax (30), or P. ovale (1), and 124 samples of healthy subjects or patients with other fever-related infections, were collect-
ed. The sensitivities of Malaria Ag-Pf
TM and Malaria Antigen Pf/Pan
TM compared with the microscopic method for P. falci-
parum or P. vivax detection were 97.6% and 99.0%, or 98.6% and 99.0%, respectively. The specificities of Malaria Ag-Pf
TM, 
Malaria Ag-Pv
TM, and Malaria Antigen Pf/Pan
TM were 93.3%, 98.8%, and 94.4%, respectively. The sensitivities of Malaria 
Ag-Pf
TM, Malaria Antigen Pf/Pan
TM, and microscopic method, when PCR was used as a reference method for P. falciparum 
or P. vivax detection were 91.8%, 100%, and 96.7%, or 91.9%, 92.6%, and 97.3%, respectively. The specificities of Ma-
laria Ag-Pf
TM, Malaria Ag-Pv
TM, Malaria Antigen Pf/Pan
TM, and microscopic method were 66.2%, 92.7%, 73.9%, and 78.2%, 
respectively. Results indicated that the diagnostic performances of all the commercial RDTs are satisfactory for applica-
tion to malaria diagnosis.
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[12]. The second type detects parasite lactate dehydrogenase 
(pLDH), an enzyme produced by all 4 human malaria species 
[13,14]. HRP2 test kits have generally shown higher sensitivity 
for P. falciparum detection and can be less costly than the pLDH 
[15-18]. Nevertheless, several studies have demonstrated that 
HRP2 remains in the blood stream for an extended time fol-
lowing successful eradication of the parasite with effective an-
timalarial treatment, contributing to false positive results and 
limited specificity [19,20]. In areas along the Thai-Myanmar 
border with a high annual malaria incidence, malaria diagno-
sis is an important tool in controlling disease morbidity and 
mortality [21]. RDTs would be an effective alternative diagnos-
tic tool or used as an adjunct to microscopy for successful ma-
laria control. 
In the present study, 3 commercial RDTs (SD BIOLINE: Stan-
dard Diagnostics, Seoul, Republic of Korea), i.e., Malaria Anti-
gen Pf/Pan
TM, Malaria Antigen Ag-Pf
TM, and Malaria Antigen 
Ag-Pv
TM, were assessed for their diagnostic performance for P. 
falciparum and P. vivax malaria. Ag-Pf
TM detects HRP2 specific 
to P. falciparum, whereas Pg-Pv
TM detects pLDH specific to P. 
vivax, and Pf/Pan
TM detects both HRP2 and pLDH specific to 
Plasmodium species in human blood. The assessment of their 
diagnostic performance was performed in comparison with 
the gold-standard microscopic and reference PCR methods. 
MATERIALS AND METHODS
Sample collection 
The study was cross-sectional and was conducted during May 
2008- April 2009 at Mae Sot General Hospital, Mae Sot District, 
Tak Province, Thailand, an area along the Thai-Myanmar bor-
der with a high annual malaria incidence (http://www.thaivbd. 
org/cms/index.php). The inclusion criteria were blood sam-
ples obtained from febrile patients (oral temperature >37.5˚C) 
with acute uncomplicated malaria and healthy subjects who 
had no previous sign of fever for at least weeks. The exclusion 
criteria were blood samples from those having previous anti-
malarial treatment or presence of clinical signs and symptoms 
of severe malaria. P. falciparum accounts for 50-60% of the Plas-
modium species in this region. A total of 584 blood samples, 
500 µl each for microscopic examination and 100 µl finger-
prick blood for PCR and RDTs, were collected for malaria di-
agnosis by 3 methods, microscopic, PCR, and RDTs. Among 
them, 460 were collected from patients with signs and symp-
toms of malaria, 72 were from patients with fever related to 
other infections (10 typhus, 17 scrub typhus, and 45 dengue 
hemorrhagic fever), and 52 normal blood samples obtained 
from blood bank of Mae Sot General Hospital. Blood smears 
of 460 malaria samples were confirmed by 2 microscopists; 
211, 218, 30, and 1 samples were identified as infections with P. 
falciparum, P. vivax, mixed infection with P. falciparum and P. 
vivax, and P. ovale, respectively. 
Malaria diagnosis
Microscopic examinations
Thick blood smears were prepared for all blood samples 
and stained with 10% Giemsa. The malaria parasite was de-
tected under light microscopy. The number of parasites was 
counted against 200 leucocytes and parasite density was esti-
mated by assuming 8,000 leucocytes/μl blood. Samples were 
considered negative when no parasite was detected after exam-
ining 100 microscopic fields. The malaria microscopic exami-
nation was performed by 2 independent experienced micros-
copists from Mae Sot General Hospital and Pharmacology and 
Toxicology Laboratory, Thammasat University, Thailand. Each 
blood slide was blinded and the result was masked to both of 
the 2 microscopists. In order to check for inter-observer vari-
ability, a double blind cross reading of a random sampling of 
100 blood slides was carried out by the senior microscopist. 
Rapid diagnostic tests (RDTs)
Malaria diagnosis by 3 commercial RDTs, i.e., Malaria Anti-
gen Pf/Pan
TM (Catalogue No.05FK60), Malaria Ag-Pf
TM (Cata-
logue No. 05FK50), and Ag-Pv
TM (Catalogue No. 05FK70) (SD 
BIOLINE) were performed in all blood samples (finger-prick 
blood) using the method described by the manufacturer (http: 
//standardia.com/html_e/mn03/mn03_01.asp). The presence 
of both the control and test lines indicated a positive result for 
P. falciparum and P. vivax, whereas the presence of only the con-
trol line indicated a negative result. All RDT kits were stored as 
directed by the manufacturer and the quality of package desic-
cant was checked before use. 
PCR analysis
PCR analysis was performed in a total of randomly selected 
129 (20%) finger-prick blood samples. The fresh blood sam-
ple (20 µl) was spotted onto a filter paper (Whatmann No. 3), 
and the dried blood spot paper was stored in a zipper plastic 
bag containing desiccant, and transported to he Pharmacology 
Unit, Graduate Program in Biomedical Sciences, Thammasat   Chaijaroenkul et al.: Rapid diagnostics for P. falciparum and P. vivax in Mae Sot, Thailand   35
University for PCR analysis. Genomic DNA was extracted us-
ing Chelex-resin (Biorad, Hercules, California, USA) according 
to the method of Wooden et al. [22]. The previously published 
nested PCR methods were employed to detect malaria species 
specific reactions [23]. The method is highly specific and can 
differentiate P. falciparum, P. vivax, and other malaria species. 
Data analysis
The performances of all RDTs were evaluated based on the 
following criteria: sensitivity, specificity, positive prediction 
value (PPV), negative prediction value (NPV), false positive 
rate, and false negative rate, in 2 separate analyses; (i) diagnos-
tic performance of the 3 RDTs in comparison with the micro-
scopic method (gold standard), and (ii) comparative diagnos-
tic performances of the 3 RDTs in comparison with the micro-
scopic method and PCR (reference). The sensitivity of the test 
was calculated as (number of true positives/[number of true 
positives+number of false negatives])×100, and the specificity 
of the test was calculated as (number of true negatives/[number 
of true negatives+number of false positives])×100, PPV and 
NPV were determined from (number of true positive/[number 
of true positive+number of false positive])×100, and (number 
of true negative/[number of true negative+number of false 
negative])×100, respectively. The false positive and the false 
negative rates were determined from 1–specificity, and 1- sen-
sitivity, respectively. The detection limit was calculated from 
the sample with the lowest parasitemia with the true positive 
result, and was confirmed by the laboratory clone P. falciparum 
culture with different dilutions of parasitemia. 
Statistical analysis was performed by the chi-square test at a 
statistical significance level of P=0.05, using the SPSS version 
12.0. 
RESULTS
Diagnostic performance of RDTs in comparison with 
microscopy 
The parasite density of P. falciparum and P. vivax were 2-70,000 
and 2-27,200 parasites/µl, respectively. A double blind cross 
reading of a random sample of 100 slides showed 1% inter-
observer variability. 
The diagnostic performances of all the 3 commercial RDTs 
were evaluated in 584 blood samples, in comparison with the 
microscopy method. Table 1 summarizes the number of blood 
samples with positive and negative detection of P. falciparum 
and P. vivax. A total of 229 and 211 samples, respectively, show-
ed positive for P. falciparum by Ag-Pf
TM and the microscopic 
method. P. vivax was detected in 219 and 218 samples by Ag-
Pv
TM and the microscopic method, respectively. P. falciparum 
and P. vivax , respectively, were detected in 232 and 200 sam-
ples by Pf/pan
TM. The sensitivity, specificity, PPV, NPV, false 
positive rate and false negative rates of the 3 RDTs compared 
with the microscopic method are shown in Table 2. The sensi-
tivity of Ag-Pf
TM and Pf/Pan
TM compared with the microscopic 
method for detection of P. falciparum was 97.6% and 99.0%, 
respectively. The sensitivity of Ag-Pv
TM and Pf/Pan
TM for detec-
Table 1. Detection of P. falciparum and P. vivax by Malaria Ag-
Pf, Ag-Pv, and Malaria Antigen Pf/Pan tests
a in comparison with 
the microscopic method 
Species (microscopy positive) Ag-Pf kit Ag-Pv kit P.f/Pan
P. falciparum (211) 229 0 232
P. vivax (218) 0 219 200
P. falciparum and P. vivax mixed (30)  29 30 28
Negative or P. ovale (125) 326 335 124
Total (584)  584 584 584
aData are presented as the number of positive samples by the 3 RDTs 
and microscopic method (in parenthesis).
Table 2. The test performance
a of Malaria Ag-Pf, Ag-Pv, and Mal  aria Antigen Pf/Pan for detection of P. falciparum and P. vivax in com-
parison with the microscopic method 
Ag-Pf  Ag-Pv  Pf/Pan 
Sensitivity for P. falciparum 97.6 (94.7-98.9) - 99.0 (96.9-99.7)
                     P. vivax - 98.6 (96.5-99.6) 99.0 (95.6-99.5)
Specificity  93.3 (90.1-95.5) 98.8 (97.0-99.5) 94.4 (88.8-97.0)
Positive predictive value (PPV)  90.0 (86.8-92.2) 98.2 (96.4-99.4) 98.2 (95.6-99.5)
Negative predictive value (NPV)  98.5 (95.3-99.7) 99.1 (97.3-99.8) 80.3 (77.7-85.5)
False positive rate  6.7 (4.5-9.9) 1.2 (0.5-3.0) 5.6 (3.0-11.2)
False negative rate  2.4 (1.1-5.3) 1.4 (0.4-35) 6.8 (4.5-9.6)
Detection limit (parasites/µl) >2-5 >2 Pf> 2-5, Pv>2
aData are presented as percentage (95% confidence interval; CI).36   Korean J Parasitol. Vol. 49, No. 1: 33-38, March 2011




TM was 93.3%, 98.8%, and 
94.4%, respectively. All the 3 RDTs showed significant correla-
tion with the microscopic method in detecting malaria para-
site species (P<0.001). Parasitemia of the false negative sam-
ples for Ag-Pf
TM and Ag-Pv
TM were 2-1,446 and 4-62 parasite/
µl, respectively. Parasitemia of the false negative samples by Pf/
pan
TM for detection of P. falciparum and P. vivax were 41-1,466 
and <20 parasites/µl, respectively. The detection limit for P. 
falciparum and P. vivax was >2 parasites/µl for all RDT tests. 
For the laboratory strain P. falciparum dilution, the detection 
limit was 5 parasites/µl.
The sensitivity of the 3 RDTs categorized by parasite density 
is summarized in Table 3. Results clearly showed lower sensi-
tivity of all RDTs in detecting both P. falciparum and P. vivax 
with parasite densities of less than 50 parasites/µl.
Diagnostic performance of RDTs, microscopy, and PCR 
methods
PCR was performed in a total of 129 randomly selected bl-
ood samples. The sensitivity, specificity, PPV, NPV, false posi-
tive and false negative rates of the 3 RDTs, and the microscopic 
method in comparison with the PCR method are shown in 
Table 4. Ag-Pf
TM showed the highest false positive rate. The sen-
sitivity of Ag-Pf
TM, Pf/Pan
TM, and the microscopic method for P. 
falciparum detection were 91.8%, 100%, and 96.7%, respective-
ly. The sensitivity of Ag-Pv
TM, Pf/Pan
TM, and the microscopic me-
thod for P. vivax detection were 91.9%, 92.6%, and 97.3%, re-
spectively. The specificity of Ag-Pf
TM, Ag-Pv
TM, Pf/Pan
TM, and the 
microscopic method were 66.2%, 92.7%, 73.9%, and 78.2%, 
respectively. All the RDTs and the microscopic method showed 
significant correlation with the PCR method in detecting cer-
tain species of malaria (P<0.001). Based on PCR results, the 
microscopic method provided the best diagnostic performance 
compared with the RDTs for detection of both P. falciparum 
and P. vivax. 
DISCUSSION
The present study demonstrated that the 3 RDTs, Malaria 
Table 3. The sensitivity
a of Malaria Ag-Pf, Ag-Pv, and Malaria Antigen Pf/Pan tests for detection of P. falciparum and P. vivax in com-
parison with the microscopic method, categorized according to parasite density 
Parasite density (parasites/μl) Ag-Pf Ag-Pv Pf/Pan
Plasmodium falciparum
   <50 (n=29) 84.2 (62.4-94.5) - 89.7 (73.6-96.4)
   50-499 (n=74) 98.7 (92.7-99.8) - 97.3 (90.7-99.3)
   500-999 (n=35) 97.1 (85.1-99.5) - 97.1 (85.5-99.5)
   1,000-4,999 (n=64) 98.4 (91.3-99.7) - 98.4 (91.7-99.7)
   >5,000 (n=38) 100    (90.8-100) - 100.   (90.8-100)
Plasmodium vivax
   <50 (n=47) - 76.6 (62.8-86.4) 78.7 (65.1-88.0)
   50-499 (n=111) - 95.5 (89.9-98.1) 93.7 (87.6-96.9)
   500-999 (n=35) - 97.1 (85.5-99.5) 94.3 (81.4-98.4)
   1,000-4,999 (n=44) - 90.9 (78.8-96.4) 84.1 (70.6-92.1)
   >5,000 (n=11) - 100    (74.1-100) 100.   (74.1-100)
aData are presented as percentage (95% CI).
Table 4. The test performance
a of Malaria Ag-Pf, Ag-Pv, Malaria Antigen Pf/Pan, and the microscopic method for detection of P. fal-
ciparum and P. vivax compared with the PCR method 
Ag-Pf Ag-Pv Pf/Pan Microscopic method 
Sensitivity for P. falciparum 91.8 (82.2-96.5) - 100.0 (85.7-100) 96.7 (83.3-99.4)
                     P. vivax - 91.9 (83.4-96.2) 92.6 (76.6-97.9) 97.3 (86.2-99.5)
Specificity  66.2 (54.3-76.3) 92.7 (82.7-97.1) 73.9 (53.5-87.5) 78.2 (58.1-90.3)
Positive predictive value (PPV) 70.9 (59.0-81.0) 94.4 (84.4-98.8) 93.5 (86.2-99.5) 95.4 (84.3-97.6)
Negative predictive value (NPV) 90.0 (80.4-94.7) 89.5 (81.0-93.8) 77.3 (56.9-90.9) 90.0 (78.1-94.2)
False positive rate 33.8 (23.7-45.7) 7.3 (3.8-16.6) 26.1 (12.5-46.5) 21.7 (9.7-41.9)
False negative rate 8.2 (3.5-17.8) 8.1 (2.9-17.3) 4.7 (1.9-11.9) 1.9 (0.9-21.2)
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Antigen Pf/Pan
TM, Malaria Antigen Ag-Pf
TM, and Malaria Anti-
gen Ag-Pv
TM showed good test performances for detection of 
both P. falciparum and P. vivax. Pf/Pan
TM is a one-step test for 
detection of HRP2 specific to P. falciparum and pLDH pan-spe-
cific to Plasmodium species in the human blood sample. Ag-
Pv
TM is a one-step detection of pLDH specific to P. vivax, and 
Ag-Pf
TM is a one-step detection of HRP2 specific to P. falciparum 
in the human blood sample. Ag-Pf
TM and Ag-Pv
TM are specific 
for detection of P. falciparum and P. vivax, respectively. Both sho-
wed excellent sensitivity and specificity.
The performance of the Ag-Pf test observed in the present 
study was in agreement with previous studies with other HRP2-
based commercial RDTs, i.e., BinaxNow Malaria
TM (Binax, Inc., 
Inverness Medical Professional Diagnostic, Scarborough, ME, 
USA) [22], Paracheck Pf
TM (Orchid Biomedical system) [22,23], 
and ParaHit PF
TM (Span Diagnostic Ltd) [22,23]. The tests also 
showed good performance when compared with pfLDH-based 
commercial RDTs, such as CareStart Malaria test
TM (AccessBio 
Inc.) [22], OptiMAL strip
TM (DiaMed AG) [13], and OptiMAL-
IT
TM (DiaMed AG) [22-24]. Malaria Ag-Pv
TM which detected 
pvLDH showed very good performance similarly to other com-
mercial RDTs, such as OptiMAL strip
TM (DiaMed AG) [13], and 
SD FK70 Malaria Antigen Pv test
TM (Standard Diagnostics, Seoul, 
Republic of Korea) [22]. The excellent performance of Pf/Pan
TM 
for detection of both P. falciparum and P. vivax observed in this 
study was also similar to that reported with OptiMAL
TM (Di-
aMed AG) [13]. Markedly variable sensitivity and specificity 
have been reported for commercially available RDTs [13,22-
35]. It is difficult to directly compare the diagnostic performan-
ces of these tests since results reported may be influenced by 
many factors, such as environmental conditions, the use of 
different gold-standards, as well as possible geographic varia-
tion in malaria antigens. All these factors should be taken into 
consideration when selecting RDTs for application to malaria 
diagnosis. 
When PCR was the reference method, the microscopic meth-
od showed a low specificity (78.2%). The false positive was 
21.7%; this was an interesting data. The explanation for this 
could be other species of Plasmodium spp. (P. knowlesi) that 
have been reported in Thailand [22,23]. The PCR method used 
as the reference could not differentiate this P. knowlesi. There-
fore, the PCR result showed negative data. However, the 5 bl-
ood slides from these samples showed malaria parasites in red 
blood cells. False negative results of RDTs were observed and 
have been attributed to possible genetic heterogeneity of HRP2 
or LDH expression, deletion of HRP2 or LDH gene, presence 
of blocking antibodies, or immune-complex formation. On 
the other hand, false positive tests can occur even in samples 
with high parasitemia, which could be due to several reasons, 
including viable asexual-stage parasitemia below the detection 
limit of microscopy (possibly due to drug resistance), persis-
tence of antigens due to sequestration and incomplete treat-
ment, delayed clearance of circulating antigen (free or in anti-
gen-antibody complexes), and cross reaction with non-falci-
parum malaria or rheumatoid factor.
In conclusion, the test performance of these 3 RDTs as ma-
laria diagnostic tools are promising. The tests could detect Plas-
modium species with high accuracy, sensitivity, and specificity. 
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